Plenary Session: Strategic approach to pharmaceuticals in the environment
Strategic approach to pharmaceuticals in the environment
I voted in favour of the resolution because it calls for the inclusion of environmental effects in the risk-benefit assessment for the approval of active substances; so that there is an environmental risk assessment for all human medicines; in order to update the requirements for the assessment of environmental risks and to make the production of imported medicines comply with the same environmental standards as medicines produced in the EU.
Guerreiro wants to avoid misleading use of the term “natural” on food products
Wednesday, 10 February 2021
Under the initiative of MEP Francisco Guerreiro (Greens/EFA), MEPs want to avoid the misleading use of the term “natural” on food products and ask the European Commission to provide a clear definition of “natural” in the European Union’s food legislation.READ MORE